I am a board certified medical oncologist with a clinical practice devoted solely to the care of patients with breast cancer. I am part of a multidisciplinary team that treats women with both early-stage and advanced disease. Through my practice, I strive to individualize medical treatment and care to each patient’s needs and preferences.
My research focuses on ways to improve patient experiences and quality of life during cancer treatment and throughout survivorship by improving management of symptoms. My research interest is in supportive care for patients and in survivorship issues facing women with breast cancer. By studying the impact of treatment on sexual function and fertility, I hope to enhance the scientific understanding of these important issues leading to improved outcomes for patients. My current projects are an evaluation of specific interventions to alleviate sexual dysfunction, an assessment of ovarian function, and the development of strategies to optimize fertility preservation.
My work integrates clinical trial methods as well as health outcomes research. I am involved in clinical trials evaluating the effects of breast cancer treatment (e.g. chemotherapy or tamoxifen) on ovarian reserve in premenopausal women. This type of work will assist in determining the likelihood of infertility from a given treatment regimen and the impact of common therapies on menstruation and future pregnancy. In postmenopausal women, I am evaluating the use of low dose vaginal estrogens to improve vaginal dryness, atrophy, recurrent urinary tract symptoms and sexual dysfunction. As part of my health outcomes research, I am developing methods and instruments to better measure symptoms, such as sexual health. A goal of this work is to develop additional interventions to decrease the burden of treatment on patients.
In addition, I am an active member of the American Society of Clinical Oncology (ASCO) and the International Society for the Study of Women’s Sexual Health (ISSWSH). I am also an active member of the survivorship working group for the Multinational Association of Supportive Care in Cancer (MASCC), an international organization devoted to the understanding of side effects in cancer patients.
- Clinical Expertise: Breast Cancer
- Languages Spoken: English
- Education: MD, Upstate Medical School
- Residencies: Internal Medicine - New York University Hospital; Internal Medicine - Memorial Sloan Kettering Cancer Center
- Fellowships: Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Shari B. Goldfarb
Clinical Trials Co-Investigated by Shari B. Goldfarb
- A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
- A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
- A Study of Treatment-Related Hair, Skin, and Nail Changes Among Women with Non-Metastatic Breast Cancer